Scilex Holding (SCLX) EPS (Basic) (2020 - 2026)
Scilex Holding (SCLX) posted quarterly EPS (Basic) of -$6.28 for Q1 2026, up 99.72% year-over-year from -$3.14 in Q1 2025, and up 99.79% on a QoQ basis from -$3000.9 in Q4 2025.
Scilex Holding (SCLX) EPS (Basic) (2020 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported EPS (Basic) for 7 consecutive years, with -$6.28 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 99.72% year-over-year to -$6.28; the TTM figure through Mar 2026 stood at -$60.9 (up 99.16% YoY), while the FY2025 annual figure was -$36477.0, down 167170.12% from the prior year.
- EPS (Basic) came in at -$6.28 for Q1 2026 at Scilex Holding, up from -$3000.9 in the prior quarter.
- The five-year high for EPS (Basic) was $57.12 in Q3 2022, with the low at -$22167.7 in Q3 2025.
- Average EPS (Basic) over 5 years is -$3532.1, with a median of -$36.29 recorded in 2022.
- Across the five-year window, EPS (Basic) soared 10097.53% in 2022 and tumbled 167254.18% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$4663.6 in 2022, then jumped by 99.88% to -$5.75 in 2023, then increased by 28.71% to -$4.1 in 2024, then plunged by 73120.85% to -$3000.9 in 2025, then jumped by 99.79% to -$6.28 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$6.28, -$3000.9, and -$22167.7 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 8.27 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 2.17 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.39 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 121.99 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -2.35 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 3.37 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.63 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.00 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | -6.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.28 |
| Dec 31, 2025 | -3,000.91 |
| Sep 30, 2025 | -22,167.70 |
| Jun 30, 2025 | -7,422.25 |
| Mar 31, 2025 | -2,255.08 |
| Dec 31, 2024 | -4.10 |
| Sep 30, 2024 | -1,209.82 |
| Jun 30, 2024 | -10,944.09 |
| Mar 31, 2024 | -8,331.17 |
| Dec 31, 2023 | -5.75 |
| Sep 30, 2023 | -22.07 |
| Jun 30, 2023 | -6.54 |
| Mar 31, 2023 | -7.60 |
| Dec 31, 2022 | -4,663.36 |
| Sep 30, 2022 | 57.12 |
| Jun 30, 2022 | -36.29 |
| Mar 31, 2022 | -18.55 |
| Dec 31, 2021 | -9,289.94 |
| Sep 30, 2021 | -0.57 |
| Jun 30, 2021 | -0.34 |